These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 263851

  • 1. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
    Millichap JG.
    Pediatrics; 1978 Jan; 61(1):146-7. PubMed ID: 263851
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pemoline (Cylert) for minimal brain dysfunction.
    Med Lett Drugs Ther; 1976 Jan 16; 18(2):5-6. PubMed ID: 1107790
    [No Abstract] [Full Text] [Related]

  • 5. The use of imipramine in Tourette's syndrome and attention deficit disorder: case report.
    Dillon DC, Salzman IJ, Schulsinger DA.
    J Clin Psychiatry; 1985 Aug 16; 46(8):348-9. PubMed ID: 2862138
    [Abstract] [Full Text] [Related]

  • 6. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE, Greenslade KE, Vodde-Hamilton M, Murphy DA, Greenstein JJ, Gnagy EM, Guthrie KJ, Hoover MD, Dahl RE.
    Pediatrics; 1990 Aug 16; 86(2):226-37. PubMed ID: 2196522
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Attention deficit hyperactivity disorder in children.
    Ramchandani P, Joughin C, Zwi M.
    Clin Evid; 2002 Dec 16; (8):280-90. PubMed ID: 12603883
    [No Abstract] [Full Text] [Related]

  • 9. The effects of stimulant medication on the growth of hyperkinetic children.
    Roche AF, Lipman RS, Overall JE, Hung W.
    Pediatrics; 1979 Jun 16; 63(6):847-50. PubMed ID: 450520
    [Abstract] [Full Text] [Related]

  • 10. Attention deficit hyperactivity disorder in children.
    Ramchandani P, Joughin C, Zwi M.
    Clin Evid; 2002 Jun 16; (7):262-71. PubMed ID: 12230649
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clonidine for stimulant-related sleep problems.
    Rubinstein S, Silver LB, Licamele WL.
    J Am Acad Child Adolesc Psychiatry; 1994 Feb 16; 33(2):281-2. PubMed ID: 8150803
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
    Varley CK.
    Psychopharmacol Bull; 1985 Feb 16; 21(2):216-21. PubMed ID: 2860692
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The hyperkinetic child: current status.
    Dubey DR.
    Compr Ther; 1982 May 16; 8(5):58-67. PubMed ID: 7094561
    [No Abstract] [Full Text] [Related]

  • 17. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
    Eisenberg L.
    Pediatrics; 1972 May 16; 49(5):709-15. PubMed ID: 4504174
    [No Abstract] [Full Text] [Related]

  • 18. Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.
    Rapport MD, Carlson GA, Kelly KL, Pataki C.
    J Am Acad Child Adolesc Psychiatry; 1993 Mar 16; 32(2):333-42. PubMed ID: 8444762
    [Abstract] [Full Text] [Related]

  • 19. Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome.
    Gross MD.
    Psychosomatics; 1975 Mar 16; 16(1):26-7. PubMed ID: 1101283
    [No Abstract] [Full Text] [Related]

  • 20. Genetic issues in the syndrome of minimal brain dysfunction.
    Omenn GS.
    Semin Psychiatry; 1973 Feb 16; 5(1):5-17. PubMed ID: 4610759
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.